ARTICLES / General / Clinical
Trials Demystified /
Other Articles
Share This Article
Clinical Trials Demystified
By Michael Plontz
It seems that every time you turn on
the television or open a magazine these days there is a
new drug being touted as the new miracle cure-all. This
is especially true of allergy and heartburn medications.
How do scientists and researchers know what works and
what does not work? Potential new drugs are first
thoroughly evaluated in the laboratory with computer
models. After this phase of testing is completed,
additional research is then performed on laboratory.
Eventually, the new drugs must be tested on human
beings. This is done in a process called a clinical
trial. It may sound as though a research facility is
being sued, but it’s even more complicated than that.
It was in 1938 that the Federal Food, Drug and Cosmetic
(FDC) Act was passed which made evidence of safety
mandatory before marketing was possible. The Kefauver-Harris
Drug Amendment passed in 1962, required that a drug’s
effectiveness, as well as its safety, had to be proven.
The Food and Drug Administration (FDA) makes the final
decision.
So what is the process? Clinical trials, also known as
investigational drug studies, are a carefully designed
research study to determine whether new treatments or
drugs are safe and effective. These trials involve using
people, but only after extensive laboratory and animal
testing show positive results.
Clinical trial protocol is a set of rules on which the
trial is based. Basic protocol consists of the following
information:
Who may participate
Test, procedure, medication and dosage schedules
Length of study
Each clinical trial proceeds through four phases. In
Phase I, scientists test a small group of 20-80 people
for the first time. A procedure or drug’s safety is
evaluated, a safe dosage range is determined, and side
effects are determined. In Phase II, the number of
participants is increased to 100-300, and safety and
effectiveness are further evaluated. Phase III increases
the amount of people tested to between 1000 and 3000.
Safety, effectiveness and side effects are again
monitored with special emphasis on safety. Phase IV
occurs after the drug or treatment has been marketed.
Information about their effect in various populations is
evaluated as well as any side effects associated with
long-term use.
As one can imagine the government regulates every facet
of these trials with strict guidelines. Every single
clinical trial in the U.S. is approved and monitored by
an Institutional Review Board (IRB) to make sure that
potential benefits far outweigh the risks involved. An
IRB is made up of a committee of physicians, community
advocates, statisticians, and others to ensure that
patients’ rights are protected and that the trial is
ethical.
In addition to government watchdogs as a check and
balance, informed consent must be given by any and all
participants. This would include:
Why is the research being conducted
What is the desired end result
What will the trial entail and how long will it last
What are the risks
What are the benefits
Are there other treatments available
May I leave the trial at any time (the answer here is
absolutely)
Age, current medical condition, type of disease being
treated, and medical history will factor into the
equation also. Participants must qualify before they can
join a study. Many times researcher will want perfectly
healthy volunteers while, in other instances, they will
want volunteers with a specific disease. Inclusion
criteria are factors that allow one to participate in a
study while exclusion factors prevent that from
happening. Once the study is set up and the participants
are chosen, the clinical trial resembles any other
experiment using a control group and either a blind or
double-blind study.
Clinical trials with human volunteers as subjects are
always necessary before a drug can be released and
approved for use. Great strides have been made in many
different areas of medicine with perhaps the greatest
strides made in HIV and AIDS research, cancer and
Alzheimer’s. Participation in these studies helps make
it possible for many people to live or lead a better
life and allows the safe release of new treatments and
cures for many diseases to become available.
Printable Version
|
|
|